# THC & Politics: A Nation Divided on How to Normalize Cannabis
Cannabis legalization is fracturing along predictable fault lines this spring, with some states charging forward on medical access and therapeutic alternatives while others are throwing up new barriers—and the federal government remains stuck in contradictions that make no scientific sense. The political landscape reveals something troubling: we're normalizing cannabis piecemeal, state by state, while the people making decisions seem increasingly uncomfortable with what legalization actually looks like when voters get what they voted for.
Start with Florida, where according to Marijuana Moment, the state Supreme Court killed a ballot measure that would have put recreational legalization to voters in 2026. The court rejected the campaign's appeal to restore thousands of signatures for the initiative—essentially ending the push before it could reach the ballot. This is the same state where Republicans are so confident in their supermajority that they're passing voter ID laws, banning DEI programs, and letting teachers unions die without a budget. [DOUBLE STANDARD WATCH] Florida's political machine is strong enough to block cannabis on a technicality, yet somehow it's voters in other states who get to decide? The inconsistency isn't an accident—it's a feature.
Meanwhile, in Oklahoma, Governor Kevin Stitt is claiming lawmakers support rolling back the state's voter-approved medical marijuana law, despite recent skepticism from GOP leadership. According to Marijuana Moment, Stitt told the Family Research Council's Tony Perkins that Oklahomans were "sold a bill of goods" and that the state now grows "32 times more marijuana than actually is consumed legally." The problem? Senate President Pro Tempore Lonnie Paxton has already said it'd be "really hard to completely undo" legalization because licensed operators "invested their life savings into this program" and are "trying to do this for the Oklahomans that need that product—not for recreational, but for actual medicinal purposes." 🤔 THINK ABOUT IT If a Republican state Senate leader thinks it's unfair to take away what voters approved, why is a Republican governor pushing so hard to overturn the will of the people? That's not leadership. That's sour grapes.
But here's where it gets interesting—and where you see the real split in cannabis politics. While some states are trying to claw back legalization, others are racing to expand access in ways that genuinely matter. 🚀 THIS IS COOL Minnesota lawmakers just approved a bill to legalize therapeutic psilocybin for adults 21 and older, as reported by Marijuana Moment, with regulated facilitators administering the psychedelic in approved settings. Colorado sent Governor Jared Polis a bill allowing terminally ill patients to use medical cannabis in hospitals. Georgia's House passed a bipartisan bill to modernize its medical cannabis program. Tennessee is relaunching its "Pot for Potholes" campaign to legalize recreational cannabis and use tax revenue for infrastructure. 💰 MONEY MOVES These aren't just policy wins—they're the beginning of recognizing cannabis as part of the healthcare and economic infrastructure of modern America. And it's happening in red states and blue states alike.
The science is already here. According to research from Columbia University reported by Medical Xpress, adopting recreational cannabis laws—beyond just medical—may help reduce the illegal cannabis market. A new study from the American Medical Association found that a single psilocybin dose combined with cognitive behavioral therapy yielded significantly greater results for treating depression and substance use disorders. Meanwhile, as millions of Americans turn 65 every year and join Medicare, many are living with chronic pain, inflammation, insomnia, and anxiety—conditions for which cannabis has proven benefit. Yet the federal government still treats it as Schedule I, the same category as heroin, while prescribing opioids that kill 16,000+ Americans annually. [DOUBLE STANDARD WATCH] Cannabis remains Schedule I while alcohol—responsible for 95,000 deaths per year—is advertised during every major sporting event. Something doesn't add up, and voters in Tennessee, Georgia, and Minnesota are calling that out.
The political resistance is real, though it's revealing itself in new ways. Arizona passed a bill to penalize people for creating "excessive" marijuana smoke or odor—as Marijuana Moment reported, making it punishable by up to four months in jail and a $750 fine if the conduct is "intentional" or "knowingly and substantially interferes" with the enjoyment of life or property. After legalization passed, Arizona voters are now getting new criminalization through the back door. New Hampshire's House simply let marijuana legalization and psilocybin therapy bills die without a floor vote—per Marijuana Moment—choosing silence over democracy. And Congress is advancing the Kids Internet and Digital Safety Act, which, as Marijuana Moment noted, would prohibit advertising cannabis products online in ways that could reach minors—a reasonable safeguard, but one that conspicuously doesn't apply to alcohol ads during March Madness.
Here's what's happening: cannabis is becoming normalized by necessity, one patient and one state at a time, while the old guard tries to slow it down through procedural tricks, new restrictions, and federal gridlock. The Senate amendment from Senator Jeff Merkley to treat marijuana industry workers' income the same as other industries for federal mortgage purposes—per Marijuana Moment—is a tiny, quiet revolution. It means the federal government is starting to acknowledge that cannabis work is real work, worthy of real financial access. But the 9th Circuit's recent decision that the Dormant Commerce Clause doesn't apply to state cannabis markets according to Reuters is creating a circuit split that will eventually reach the Supreme Court. The legal architecture of cannabis normalization is fragmenting. When courts can't agree on basic rules, states are going to keep doing their own thing—and some will legalize while others build new walls. That's not a stable system. That's a system waiting for federal action that may never come. So here's the real question: if voters in Florida, Oklahoma, and Arizona can't trust their representatives to honor what they voted for, why should any of us believe this piecemeal approach to cannabis normalization is actually working?
# Hemp Ban Watch: Texas Smokable Hemp Ban Takes Effect March 31 as Multi-State Crackdown Looms
Texas is about to become ground zero for what industry insiders are calling an effective ban on smokable hemp—and the ripple effects are spreading across the country faster than anyone predicted. In just over two weeks, as of March 31, buying a joint of legal hemp flower in Texas will be illegal, marking a seismic shift in a market that's been thriving in the gray space between federal law and state regulation since 2019. The Texas Department of State Health Services finalized new rules on March 6 that redefine how THC content is measured in hemp products, shifting from testing only delta-9 THC (the primary psychoactive compound) to testing "total THC"—which includes THCA, the precursor that converts to delta-9 when heated. 💰 MONEY MOVES That single regulatory change is about to crater a $10-12 billion Texas market that employs over 50,000 people, according to Mark Bordas, executive director of the Texas Hemp Business Council, speaking to Yahoo News.
Here's where it gets absurd: the rule doesn't ban intoxicating hemp drinks or edibles—only smokable flower and extracts. That's not a public health policy. That's regulatory theater. Nicholas Mortillaro, a hemp store operator, told Yahoo News that smokable hemp is the most commonly ordered product across the state, meaning retailers are looking at "60-70% declines in businesses" within three weeks. One anonymous shop owner said the rules will "effectively shut down our businesses overnight." We're talking about small retailers—vape shops, hemp stores, family operations—getting deleted from the economy because a state health agency decided to change the testing metric without offering a transition period or alternative pathway. Meanwhile, someone can walk into a gas station and buy a legal THC seltzer. [DOUBLE STANDARD WATCH] Cannabis remains Schedule I while alcohol—responsible for 95,000 deaths per year—is advertised during every major sporting event. But intoxicating hemp drinks? Those are fine in Texas. The logic here isn't public safety. It's selective enforcement dressed up in regulatory language.
And Texas isn't alone. Ohio is preparing its own hemp ban, with CBD stores and breweries facing an uncertain future as the state moves to restrict hemp and THC drinks, according to The Columbus Dispatch. South Carolina is actively polling residents on whether to ban intoxicating hemp products entirely, as reported by The State Columbia. Federal lawmakers are also "considering a sweeping ban on THC products," according to reporting from Dallas Observer. This isn't a Texas problem anymore—it's a coordinated crackdown that's turning the legal hemp market into a patchwork of prohibition that makes less sense by the day.
What's infuriating is the path we took to get here. In 2019, a definitional change in federal hemp law created a legal loophole: as long as a product contained less than 0.3% delta-9 THC, it was federally legal. Manufacturers responded by growing plants loaded with THCA, which converts to delta-9 at an 88% rate when smoked. That was the deal. That was the law. People built businesses on it. Employees got hired. Tax revenue flowed. Then, in 2025, lawmakers tried to ban hemp-derived THC outright through Senate Bill 3, but Gov. Greg Abbott vetoed it—only to turn around and ask state health agencies to regulate it so heavily that it amounts to a ban anyway. Abbott issued an executive order asking for "stricter regulations," and DSHS delivered exactly what he wanted: a measurement standard so restrictive that virtually no smokable hemp product can meet it. The Texas Hemp Business Council's Bordas called this "an attempt to ban the industry" in slightly more measured language, but let's be clear: that's what this is. It's prohibition, just with a regulatory veneer.
Here's the part that should make you angry: 🤔 THINK ABOUT IT if a product is legal one day and illegal the next, and the only thing that changed was how you measure it—not the actual chemical composition of the plant—whose interests are actually being protected here? It's not consumers. Intoxicating drinks are still legal. It's not public health. If THC is dangerous when smoked, why is it safe when ingested? The answer is that this isn't about safety at all. This is about market control. Some legislators, led by Lt. Gov. Dan Patrick, fought hard to ban hemp products entirely. When they lost that fight, they moved to Plan B: let the industry exist, but regulate it into oblivion. Heather Fazio, director of the Texas Cannabis Policy Center, told Dallas Observer that the new standard will "drive consumers to other, even less legal sources," handing the market to illicit operators because "legitimate businesses can no longer sell it." [DOUBLE STANDARD WATCH] We say we want regulated, tested, safe products. But when businesses actually try to offer exactly that, we change the rules mid-game and force them underground.
The Texas rules also hiked licensing fees—retail businesses now pay $5,000 annually, manufacturers $10,000—which DSHS says will cover regulatory costs. But here's the thing: those fees are actually lower than previously proposed amounts, which suggests some negotiation happened. The problem is that lower fees don't matter if you can't sell your product. And while the new DSHS regulation does tighten some consumer protections and set age limits, those gains don't offset the fundamental destruction of a legal market. The Texas Hemp Business Council warned that closing stores and manufacturing operations will cost the state jobs and billions in economic activity. Nobody asked whether that trade-off was worth it. Nobody asked whether drivers would make drivers safer or whether emergency room visits would drop. The policy just landed.
What happens next matters beyond Texas. If other states follow this playbook—and Ohio and South Carolina suggest they will—you're looking at the steady evisceration of the legal hemp market without ever passing a formal "ban." The beauty of prohibition through regulation is that it looks procedural. It looks neutral. A health agency just changed how we test products. Nobody has to take a vote. Nobody has to be accountable. But the effect is the same: legal businesses close, workers lose jobs, and people who used these products legally yesterday become criminals tomorrow. 🚀 THIS IS COOL In contrast, the National Hemp Association has been championing industrial hemp—fiber, grain, and seed—as the real future of the crop, with 2024 showing a 23% jump in fiber production and hemp seed production exploding 482% in value to $16.9 million. That's the hemp story worth telling: a crop that regenerates soil, requires minimal pesticides, and feeds people and industries. But that story gets buried when we're busy banning the product people actually want to buy. The conversation should be about why we're protecting one market while destroying another, and what that says about who gets to decide which plants matter.
# THC in Science: Memory, Liver Disease, and the Growing Case for Adult Access
Researchers at Washington State University have found something troubling about how THC works in the brain — and it challenges everything casual users think they know about cannabis. According to a study published in the *Journal of Psychopharmacology*, THC doesn't just make memories fuzzy. It actually creates false ones. In controlled experiments, regular cannabis users were significantly more likely to recall words that were never shown to them and struggled with everyday memory tasks like remembering to do something later. What surprised the research team most? 🚀 THIS IS COOL Even moderate doses of 20 milligrams produced memory disruption almost identical to much higher doses of 40 milligrams, meaning you don't need to consume a lot for THC to broadly interfere with multiple memory systems at once — verbal recall, source memory, prospective memory, and temporal order memory all took hits. The study, which examined 120 participants across seven different types of memory tests, is one of the most comprehensive examinations of cannabis's cognitive effects to date. This matters because it's the kind of honest science that lets adults make informed decisions, rather than pretending the plant has zero downsides.
But while THC presents real cognitive tradeoffs, other cannabis compounds are showing genuine medical promise that's hard to ignore. Researchers at the Hebrew University of Jerusalem found that cannabidiol (CBD) and cannabigerol (CBG) — the non-intoxicating compounds in cannabis — could reverse metabolic dysfunction-associated steatotic liver disease (MASLD), a condition affecting roughly one-third of the global adult population. The mechanism is remarkable: CBD and CBG trigger a "metabolic remodeling" process that increases phosphocreatine (which strengthens cells against strain) and boosts cathepsin enzymes that clean out harmful toxins. The compounds essentially teach the liver to manage energy better and clean itself more efficiently. Additionally, researchers from Italian universities found that cannabis essential oil reduced pain, improved mobility, and eased anxiety and depression in multiple sclerosis models, with effects driven specifically by the CB2 receptor — meaning they had nothing to do with intoxication. 🚀 THIS IS COOL These aren't fringe findings; they're published in peer-reviewed journals like *Phytomedicine* and the *British Journal of Pharmacology*. The question is: why aren't these compounds being fast-tracked through human trials instead of sitting in research limbo?
Now Medicare is about to answer that question in its own way. According to MarketWatch, a proposal expected to launch as early as April 2026 would give Medicare beneficiaries up to $500 annually to purchase CBD products — a direct acknowledgment that millions of seniors live with chronic pain, sleep disorders, and anxiety that current medications aren't adequately addressing. 💰 MONEY MOVES This program could reshape the entire landscape of senior healthcare and pharmaceutical spending, especially when you consider that it's designed partly to reduce reliance on opioids and benzodiazepines, two drug classes that kill tens of thousands of Americans every year. The comparison is stark: prescription opioids kill over 16,000 Americans annually. Benzodiazepines contribute to thousands more overdose deaths. Cannabis has zero recorded overdose deaths in human history. So here's the real tension: we're about to spend federal money on a plant that's been Schedule I for over 50 years, while the medications it's meant to replace remain freely prescribed. [DOUBLE STANDARD WATCH] A substance with a zero-death record is classified as having no medical value, while substances that kill thousands remain in every medicine cabinet in America. How does that logic hold up to scrutiny?
The challenge, though, is quality and consistency. Medical Xpress reported that delta-8 THC products — marketed as "legal cannabis" alternatives — are showing up in youth-oriented packaging with wildly inconsistent labeling and doses that often exceed what's on the label. These aren't regulated like pharmaceuticals; they're marketed like novelties. That's exactly what happens when you try to work around prohibition instead of through it. If we're genuinely concerned about protecting young people, we need actual regulation, testing standards, and age restrictions — not a prohibition that pushes people toward unregulated black market alternatives. A new study from Columbia University's Mailman School of Public Health found that states adopting recreational cannabis laws beyond just medical access actually shrink illegal markets. The legal market undercuts the black market by being safer, more transparent, and more reliable. Prohibition doesn't eliminate cannabis use; it just eliminates oversight.
The research on CBD-dominant products is particularly important for older adults. A study published in the *Journal of Pain Research* analyzed real-world data from the German Pain e-Registry and found that CBD-dominant full-spectrum extracts outperformed pure THC in seniors aged 65 and older with chronic pain. 🚀 THIS IS COOL The CBD group had stronger pain relief *and* fewer side effects — 15.5% experienced adverse reactions compared to 35.7% in the THC-only group. The difference was statistically significant across every major measure: pain intensity, disability, sleep quality, daily functioning, and emotional wellbeing. This is exactly the kind of data Medicare needs to see, and it suggests that the upcoming CBD program might actually be well-designed around real evidence rather than political theater. The researchers were careful to note these findings are exploratory and need confirmation in randomized trials, but they're building a picture of cannabis compounds as legitimate therapeutic tools — not something to fear, but something to study seriously and deploy thoughtfully.
Here's what this week's science is really telling us: cannabis contains dozens of compounds, some with real risks (THC's effect on memory formation) and some with genuine benefits (CBD and CBG's effects on liver function and inflammation). The honest conversation isn't "cannabis is harmless" or "cannabis is dangerous." It's "cannabis is complex, and we need to let adults and patients access it under medical supervision, with proper labeling, consistent dosing, and real research into what works for whom." We've had 50 years to figure this out, and instead we've criminalized millions of people for using a plant while we continue to advertise a substance that kills 95,000 Americans annually on every billboard in the country. 🤔 THINK ABOUT IT If the goal is actually to protect public health and give patients access to therapeutics, why are we still treating cannabis like a Schedule I drug with no medical value when the research keeps proving otherwise? The plant isn't changing. Our understanding of it is.
Texas just effectively banned smokable cannabis by changing how the state measures THC, and the move reveals a fundamental contradiction in American drug policy that's impossible to ignore.
Starting March 31, the Texas Department of State Health Services' new rules will prohibit the sale of virtually all smokable hemp products—flower, joints, extracts—by measuring "total THC" instead of just Delta-9 THC. Here's the catch: most legal hemp on the market contains THCA, a non-psychoactive compound that converts to Delta-9 (the intoxicating part) when heated. By counting THCA in the total THC calculation, regulators have engineered a ban so strict that according to Marijuana Moment, industry advocates estimate it will hand "50 percent of the legal market to illicit operators, making our state less safe." That's not regulation. That's prohibition dressed in bureaucratic language.
The rules came after Governor Greg Abbott vetoed a legislative attempt to ban hemp-derived THC outright last year, instead issuing an executive order demanding "stricter regulations" through state agencies. The DSHS responded with a framework that technically allows edibles and infused drinks—but bans the product form Texans actually want. 💰 MONEY MOVES Retail businesses now face $5,000 annual licensing fees (up from $150), while manufacturers pay $10,000 yearly (up from $250). These fees are lower than initially proposed, which advocates like Heather Fazio of the Texas Cannabis Policy Center called a "direct victory"—but the smokable ban more than erases that win. Shop owners are bracing for collapse. One hemp store operator told reporters he expects "60-70% declines" in business within three weeks, with some operators facing complete shutdown.
[DOUBLE STANDARD WATCH] Texas is banning a plant product with zero recorded overdose deaths in human history while alcohol—which kills approximately 95,000 Americans every year—remains not just legal but celebrated in advertising, sports broadcasts, and convenience stores on every corner. Why is one Schedule I and the other sold next to the cereal? The inconsistency becomes starker when you consider that over 8,000 hemp retailers operate across Texas, employing an estimated 50,000 people in a market generating $10-12 billion annually. This isn't a fringe industry. It's a functioning market that consumers clearly want, built on a product the federal government itself legalized in 2018 under the Farm Bill. Yet state-level regulators can still strangle it through testing standards designed to fail.
There's another layer here worth examining. According to The Texas Tribune, local and federal law enforcement have raided more than 15 hemp businesses since August 2024—seizing cash, vehicles, and assets from owners who many haven't been charged with crimes. Attorneys representing these businesses say the raids, combined with impossible-to-meet regulatory standards, may be designed to build public momentum for something lawmakers couldn't pass legislatively. One attorney noted the raids have continued at the same pace even after the governor's veto, with expectations they'll increase once new enforcement budgets justify the scrutiny. The pattern is unmistakable: regulate through raids, then regulate through rules so strict the business becomes unviable anyway.
🤔 THINK ABOUT IT Texas voters were promised "regulation," not prohibition. What we're seeing is prohibition with extra steps—and a licensing fee attached. The medical cannabis program is quietly expanding (nine new licenses approved), showing that state officials *can* regulate cannabis responsibly when they choose to. But for adults who want a smokable hemp product that has harmed exactly zero people in recorded history? The state has decided that's too dangerous to allow. Meanwhile, Texas teenagers can grab a beer at a convenience store, and nobody calls that child endangerment. Something in that calculus doesn't add up, and Texans deserve to ask why their state regulators are banning a zero-death product while leaving the substance that kills nearly 100,000 Americans annually completely unrestricted.
